| abstract |
The present invention provides a compound that specifically suppresses activation of precursor plasma hyaluronan binding protein (pro-PHBP), and an anticancer agent or an anti-inflammatory agent using the compound. SOLUTION: Tyrphostin AG538, Ellagic acid dihydrate, Hamamelitannin, (-)-Epicatechinglate, (-)-Epigallocatingallate, I-Ome-AG538, (-)-ECG-3'-EC-- A pharmaceutical composition comprising 4′-O-ME, Fistindin chloride, Pyrocatechol violet, Chicoric acid, rutin, Quercetin, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid as an active ingredient. [Selection figure] None |